XLXiang Li

Xiang Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiang Li has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Allergic Bronchopulmonary Aspergillosis Aided by Bronchoalveolar Lavage: A Case Report

    by Hongyun Zhang, Lijing Jiang, Hehao Li, Ling Zhang, Xiang Li, Junpei Zhang

    This protocol establishes a clear primary goal: to develop a structured, actionable diagnostic workflow that enables accurate differentiation of allergic bronchopulmonary aspergillosis (ABPA) from other chronic respiratory diseases with similar presentations in young patients with refractory respiratory symptoms. In this population, ABPA is frequently misdiagnosed due to non-classical clinical features, leading to avoidable delays in targeted therapy and persistent diagnostic uncertainty in routine clinical practice. The diagnostic workflow is designed as an integrated, multi-step approach incorporating comprehensive clinical assessment, high-resolution computed tomography (HRCT), bronchoscopy, and bronchoalveolar lavage fluid (BALF) analysis, including galactomannan assay, alongside targeted next-generation sequencing (tNGS) to detect Aspergillus fumigatus sequence reads. These components function as adjunctive tools within a holistic framework, guiding clinicians through the sequential evaluation of atypical ABPA cases. To demonstrate clinical applicability, the workflow was implemented in a 22-year-old male patient with a 10-year history of recurrent cough and sputum production, who had been initially misdiagnosed with infectious bronchiectasis and was unresponsive to antibacterial therapy. Application of the workflow enabled integration of serial HRCT findings, BALF testing, tNGS results for Aspergillus fumigatus sequence reads, and baseline serological data, ultimately leading to a definitive diagnosis of ABPA. This protocol highlights that a multimodal diagnostic strategy can enhance diagnostic confidence in young patients with refractory respiratory symptoms and elevated serum IgE levels, reducing diagnostic ambiguity and facilitating timely initiation of targeted anti-inflammatory and antifungal therapy to improve clinical outcomes.

  • Open Access

    Refractory abdominal compartment syndrome secondary to ruptured abdominal aortic aneurysm treated with total colectomy and upper rectal resection: A case report and literature review

    by Yangyang Jiang, Jindi Ni, Lu Zhang, Lijing Jiang, Xiang Li

    Rationale: Ruptured abdominal aortic aneurysm (RAAA) is a critical condition often complicated by multiple organ dysfunction syndrome (MODS), which can significantly impede recovery following surgical intervention. Abdominal compartment syndrome (ACS) is a widely recognized but highly lethal postoperative complication. Patient concerns: A 69-year-old male presented with acute abdominal pain and hemorrhagic shock. Diagnoses: RAAA with active extravasation was confirmed, and following surgical repair, the patient developed MODS, including hepatorenal failure and acute respiratory distress syndrome. Twenty-one days postoperatively, secondary ACS led to colonic ischemia. Interventions: The patient was managed using staged surgical interventions, including decompressive laparotomy, negative pressure wound therapy systems, and definitive total colectomy with upper rectal resection due to refractory ACS characterized by transmural colonic necrosis. Outcomes: The patient showed significant recovery and was discharged after 81 days of hospitalization. At 1-month follow-up, he reported normal oral intake and no recurrence of major complications. Lessons: This case illustrates the effectiveness of a phased damage control strategy in managing high-risk RAAA patients, demonstrating that early prediction, timely intervention, and multidisciplinary care can significantly improve survival outcomes.

  • Open Access

    Impact of TLR5 overexpression on gut microbiota and metabolites: Insights into Salmonella infection outcomes

    by Xu Zhao, Chen Lei, Yue Wang, Lu Zhang, Weiyi Tang, Zhi Li, Lijing Jiang, Xiang Li

  • Open Access

    The Clinical Impact of Metagenomic Next-Generation Sequencing (mNGS) Test in Hospitalized Patients with Suspected Sepsis: A Multicenter Prospective Study

    by Yi-Hui Zuo, Yi-Xing Wu, Wei-Ping Hu, Yan Chen, Yu-Ping Li, Zhen-Ju Song, Zhe Luo, Min-Jie Ju, Min-Hua Shi, Shu-Yun Xu, et al.

    Background: Metagenomic Next Generation Sequencing (mNGS) has the potential to detect pathogens rapidly. We aimed to assess the diagnostic performance of mNGS in hospitalized patients with suspected sepsis and evaluate its role in guiding antimicrobial therapy. Methods: A multicenter, prospective cohort study was performed. We enrolled patients with suspected sepsis, collected clinical characteristics and blood samples, and recorded the 30-day survival. Diagnostic efficacy of mNGS test and blood culture was compared, and the clinical impact of mNGS on antibiotic regimen modification was analyzed. Results: A total of 277 patients were enrolled, and 162 were diagnosed with sepsis. The mortality was 44.8% (121/270). The mNGS test exhibited shorter turn-out time (27.0 (26.0, 29.0) vs. 96.0 (72.0, 140.3) hours, p < 0.001) and higher sensitivity (90.5% vs. 36.0%, p < 0.001) compared with blood culture, especially for fungal infections. The mNGS test showed better performance for patients with mild symptoms, prior antibiotic use, and early stage of infection than blood culture, and was capable of guiding antibiotic regimen modification and improving prognosis. Higher reads of pathogens detected by mNGS were related to 30-day mortality (p = 0.002). Conclusions: Blood mNGS testing might be helpful for early etiological diagnosis of patients with suspected sepsis, guiding the antibiotic regimen modification and improving prognosis.


  • Open Access

    Clinical application and evaluation of a new type of tracheal catheter fixation belt

    by Fang Niu, Qinghua Liu, Xiaohui Li, Xiang Li

    Aim: To evaluate a new fixation band for tracheal catheter in intensive care unit.Design: A cross‐sectional study.Methods: A total of 90 patients admitted to the ICU between August 2018–February 2019 were enrolled in the study. Patients were randomly divided into experimental group and control group (N = 45/per each group). 3 M strong adhesive tape and a new tracheal catheter fixation band were applied to patients in two groups, respectively. The fixation effect, incidence of mucosal pressure injury and nursing cost were evaluated.Results: Forty‐three patients from the experimental group and 42 patients from the control group participated in this study. Mild, moderate and severe catheter dislocation happened in 2, 0, 0 cases in the experimental group, and 6, 3 and 2 cases in the control group, respectively; the difference was statistically significant. The rates of mucosal pressure injury were 4.7% and 21.4%, which was significantly different, and the experiment group had a lower average daily nursing cost related to tracheal intubation.Conclusions: The new tracheal catheter fixation band, which allows for accurate fixation, is simple to operate, may reduce the incidence of mucosal pressure injury, decrease the nursing cost and improve the patients' comfort in clinical practice.


  • Open Access

    Construction of immune cell infiltration protein network based on clinical low grade glioma cases

    by Wei Jiang, Zijian He, Weizhong Jiang, Jiarui Du, Lutao Yuan, Cong Luo, Xiang Li, Fulin Xu

    Many researchers have studied low-grade glioma and the immune microenvironment have been studied by many researchers. Recent studies suggest that macrophages and dendritic cells trigger part of the local immune dysregulation in the tumor microenvironment, and they have been polarized into a mixed pro-inflammatory and immunosuppressive phenotype. It is suggested that the degree of immune infiltration is related to the survival, therapeutic effect, and prognosis of patients. This opens up new avenues for cancer treatment. On the basis of immune infiltration degree, a protein interaction network (PIN) and a prognosis model were established, and we chose the top 20 pathways from enrichment analysis to provide potential targets for glioma clinical treatment.


  • Open Access

    The Identification of Key Genes and Biological Pathways in Heart Failure by Integrated Bioinformatics Analysis

    by Qianhong Yang, Xiaolu Bai, Xiang Li, Wei Hu

    Purpose. Heart failure (HF) is a clinical syndrome caused by ventricular insufficiency. In order to further explore the biomarkers related to HF, we apply the high-throughput database. Materials and Methods. The GSE21610 was applied for the differentially expressed gene (DEG) analysis. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was performed to assess Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The Gene Set Enrichment Analysis (GSEA) was used for gene expression profile GSE21610. The Protein-Protein Interaction (PPI) network and modules were also constructed for research. These hub gene function pathways were estimated in HF progression. Result. We have identified 434 DEGs in total, including 304 downregulated DEGs and 130 upregulated DEGs. GO and KEGG illustrated that DEGs in HF were significantly enriched in G protein-coupled receptor binding, peroxisome, and cAMP signaling pathway. GSEA results showed gene set GSE21610 was gathered in lipid digestion, defense response to fungus, and intestinal lipid absorption. Finally, through analyzing the PPI network, we screened hub genes CDH1, TFRC, CCL2, BUB1B, and CD19 by the Cytoscape software. Conclusion. This study uses a series of bioinformatics technologies to obtain hug genes and key pathways related to HF. These analysis results provide us with new ideas for finding biomarkers and treatment methods for HF.


  • Open Access

    Correction to: epidemiological and genomic characteristics of A. baumannii from different infection sites using comparative genomics

    by Xingchen Bian, Xiaofen Liu, Xuefei Zhang, Xin Li, Jing Zhang, Huajun Zheng, Sichao Song, Xiang Li, Meiqing Feng


  • Open Access

    Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics

    by Xingchen Bian, Xiaofen Liu, Xuefei Zhang, Xin Li, Jing Zhang, Huajun Zheng, Sichao Song, Xiang Li, Meiqing Feng

    Background: Acinetobacter baumanniiis a common nosocomial pathogen that poses a huge threat to global health. Owing to the severity ofA. baumanniiinfections, it became necessary to investigate the epidemiological characteristics ofA. baumanniiin Chinese hospitals and find the reasons for the high antibiotic resistance rate and mortality. This study aimed to investigate the epidemiologic and genetic characteristics ofA. baumanniiisolated from patients with hospital acquired pneumonia (HAP), bloodstream infection (BSI) and urinary tract infection (UTI) in China and uncover potential mechanisms for multi-drug resistance and virulence characteristics ofA. baumanniiisolates.Results: All isolates were classified into two primary clades in core gene-based phylogenetic relationship. Clonal complex 208 (CC208) mainly consisted of ST195 (32 %) and ST208 (24.6 %). CC208 and non-CC208 isolates had carbapenem resistance rates of 96.2 and 9.1 %, respectively. Core genes were enriched in ‘Amino acid transport and metabolism’, ‘Translation’, ‘Energy production and conversion’, ‘Transcription’, ‘Inorganic ion transport and metabolism’ and ‘Cell wall/membrane/envelope synthesis’. Most isolates possessed virulence factors related to polysaccharide biosynthesis, capsular polysaccharide synthesis and motility. Eleven isolates belong to ST369 or ST191 (oxford scheme) all had the virulence factorcap8Eand it had a higher positive rate in UTI (35.3 %) than in BSI (18.9 %) and HAP (12.9 %). ABGRI1 antibiotic resistance islands were responsible for streptomycin, tetracycline and sulfonate resistance. TheblaOXA−23gene was the most probable cause for carbapenem resistance, although theblaOXA−66gene with nonsynonymous SNPs (F82L, I129L) was not.Conclusions: A. baumanniiis a genomically variable pathogen that has the potential to cause a range of infectious diseases. There is high proportion of carbapenem resistance in isolates from all three infection sites (HAP, BSI and UTI), which can be attributed to theblaOXA−23gene. CC208 is the predominant clone inblaOXA−23-carryingA. baumanniithat should be monitored. Virulence factors involving bacteria motility and polysaccharide biosynthesis which are widespread in clinicalA. baumanniistrains deserve our attention.


  • Open Access

    Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment

    by Duopeng An, Xiaochen Yu, Lijing Jiang, Rui Wang, Peng He, Nanye Chen, Xiaohan Guo, Xiang Li, Meiqing Feng

    Multidrug resistance (MDR) remains a major problem in cancer therapy and is characterized by the overexpression of p-glycoprotein (P-gp) efflux pump, upregulation of anti-apoptotic proteins or downregulation of pro-apoptotic proteins. In this study, an Apolipoprotein A1 (ApoA1)-modified cationic liposome containing a synthetic cationic lipid and cholesterol was developed for the delivery of a small-molecule chemotherapeutic drug, doxorubicin (Dox) to treat MDR tumor. The liposome-modified by ApoA1 was found to promote drug uptake and elicit better therapeutic effects than free Dox and liposome in MCF-7/ADR cells. Further, loading Dox into the present ApoA1-liposome systems enabled a burst release at the tumor location, resulting in enhanced anti-tumor effects and reduced off-target effects. More importantly, ApoA1-lip/Dox caused fewer adverse effects on cardiac function and other organs in 4T1 subcutaneous xenograft models. These features indicate that the designed liposomes represent a promising strategy for the reversal of MDR in cancer treatment.